27
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI

, ORCID Icon, , , , & ORCID Icon show all
Pages 941-952 | Received 19 Mar 2024, Accepted 17 May 2024, Published online: 24 May 2024

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–750. doi:10.1002/hep.29913
  • Hanazaki K, Kajikawa S, Shimozawa N, et al. Hepatic resection for large hepatocellular carcinoma. Am J Surg. 2001;181(4):347–353. doi:10.1016/s0002-9610(01)00584-0
  • Lin WP, Xing KL, Fu JC, et al. Development and validation of a model including distinct vascular patterns to estimate survival in hepatocellular carcinoma. JAMA Network Open. 2021;4(9):e2125055. doi:10.1001/jamanetworkopen.2021.25055
  • Yao LQ, Chen ZL, Feng ZH, et al. Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: a multi-institutional analysis. Ann Surg Oncol. 2022;29(8):5206. doi:10.1245/s10434-022-11454-y
  • Chan AWH, Zhong J, Berhane S, et al. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J Hepatol. 2018;69(6):1284–1293. doi:10.1016/j.jhep.2018.08.027
  • Lee S, Kim SH, Lee JE, et al. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol. 2017;67(3):526–534. doi:10.1016/j.jhep.2017.04.024
  • Famularo S, Piardi T, Molfino S, et al. Factors affecting local and intra hepatic distant recurrence after surgery for Hcc: an alternative perspective on microvascular invasion and satellitosis - a Western European Multicentre Study. J Gastrointest Surg. 2021;25(1):104–111. doi:10.1007/s11605-019-04503-7
  • Kim AY, Sinn DH, Jeong WK, et al. Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma. J Hepatol. 2018;68(6):1144–1152. doi:10.1016/j.jhep.2018.01.024
  • Ariizumi S, Kitagawa K, Kotera Y, et al. A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2011;18(4):575–585. doi:10.1007/s00534-010-0369-y
  • Jiang H, Wei J, Fu F, et al. Predicting microvascular invasion in hepatocellular carcinoma: a dual-institution study on gadoxetate disodium-enhanced MRI. Liver Int. 2022;42(5):1158–1172. doi:10.1111/liv.15231
  • Rhee H, An C, Kim HY, et al. Hepatocellular carcinoma with irregular rim-like arterial phase hyperenhancement: more aggressive pathologic features. Liver Cancer. 2019;8(1):24–40. doi:10.1159/000488540
  • Zhang L, Yu X, Wei W, et al. Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology. Eur Radiol. 2020;30(10):5327–5336. doi:10.1007/s00330-020-06895-6
  • Kim H, Park MS, Choi JY, et al. Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol. 2009;19(7):1744–1751. doi:10.1007/s00330-009-1331-8
  • Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018;289(3):816–830. doi:10.1148/radiol.2018181494
  • Shin J, Lee S, Kim SS, et al. Characteristics and early recurrence of hepatocellular carcinomas categorized as LR-M: comparison with those categorized as LR-4 or 5. J Magn Reson Imaging. 2021;54(5):1446–1454. doi:10.1002/jmri.27650
  • Wang L, Feng B, Li D, et al. Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters. Eur Radiol. 2023;33(5):3592–3603. doi:10.1007/s00330-023-09484-5
  • Kim KA, Kim MJ, Jeon HM, et al. Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images. J Magn Reson Imaging. 2012;35(3):629–634. doi:10.1002/jmri.22876
  • Zhu Y, Feng B, Cai W, et al. Prediction of microvascular invasion in solitary AFP-negative hepatocellular carcinoma ≤ 5 cm using a combination of imaging features and quantitative dual-layer spectral-detector CT parameters. Acad Radiol. 2023;30(Suppl 1):S104–S116. doi:10.1016/j.acra.2023.02.015
  • Liu HF, Zhang YZ, Wang Q, et al. A nomogram model integrating LI-RADS features and radiomics based on contrast-enhanced magnetic resonance imaging for predicting microvascular invasion in hepatocellular carcinoma falling the Milan criteria. Transl Oncol. 2023;27:101597. doi:10.1016/j.tranon.2022.101597
  • Kitao A, Zen Y, Matsui O, et al. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. Radiology. 2009;252(2):605–614. doi:10.1148/radiol.2522081414
  • Kovac JD, Ivanovic A, Milovanovic T, et al. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. Radiol Oncol. 2021;55(2):130–143. doi:10.2478/raon-2021-0004
  • Sheng Y, Wang Q, Liu HF, et al. Preoperative nomogram incorporating clinical factors, serological markers and LI-RADS MRI features to predict early recurrence of hepatocellular carcinoma treated with transarterial chemoembolization. Acad Radiol. 2023;30(7):1288–1297. doi:10.1016/j.acra.2022.10.020
  • Wei H, Jiang H, Zheng T, et al. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection. Eur Radiol. 2021;31(4):2289–2302. doi:10.1007/s00330-020-07303-9
  • Zhang K, Xie SS, Li WC, et al. Prediction of microvascular invasion in HCC by a scoring model combining Gd-EOB-DTPA MRI and biochemical indicators. Eur Radiol. 2022;32(6):4186–4197. doi:10.1007/s00330-021-08502-8
  • Zhang S, Huo L, Zhang J, et al. A preoperative model based on gadobenate-enhanced MRI for predicting microvascular invasion in hepatocellular carcinomas (≤ 5 cm). Front Oncol. 2022;12:992301. doi:10.3389/fonc.2022.992301
  • Hong SB, Choi SH, Kim SY, et al. MRI features for predicting microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer. 2021;10(2):94–106. doi:10.1159/000513704
  • Chen Z, Li X, Zhang Y, et al. MRI features for predicting microvascular invasion and postoperative recurrence in hepatocellular carcinoma without peritumoral hypointensity. J Hepatocell Carcinoma. 2023;10:1595–1608. doi:10.2147/JHC.S422632
  • Tang Y, Lu X, Liu L, et al. A reliable and repeatable model for predicting microvascular invasion in patients with hepatocellular carcinoma. Acad Radiol. 2023;30(8):1521–1527. doi:10.1016/j.acra.2023.02.035
  • Zheng X, Xu YJ, Huang J, et al. Predictive value of radiomics analysis of enhanced CT for three-tiered microvascular invasion grading in hepatocellular carcinoma. Med Phys. 2023;50(10):6079–6095. doi:10.1002/mp.16597
  • Yang WL, Zhu F, Chen WX. Texture analysis of contrast-enhanced magnetic resonance imaging predicts microvascular invasion in hepatocellular carcinoma. Eur J Radiol. 2022;156:110528. doi:10.1016/j.ejrad.2022.110528
  • Nino-Murcia M, Olcott EW, Jeffrey RB, et al. Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT. Radiology. 2000;215(3):746e51. doi:10.1148/radiology.215.3.r00jn03746
  • Segal E, Sirlin CB, Ooi C, et al. Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol. 2007;25(6):675–680. doi:10.1038/nbt1306
  • Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology. 2014;273(1):30–50. doi:10.1148/radiol.14132362
  • Cerny M, Chernyak V, Olivié D, et al. LI-RADS Version 2018 Ancillary Features at MRI. Radiographics. 2018;38(7):1973–2001. doi:10.1148/rg.2018180052
  • Bao Y, Li JX, Zhou P, et al. Identifying proliferative hepatocellular carcinoma at pretreatment CT: implications for therapeutic outcomes after transarterial chemoembolization. Radiology. 2023;308(2):e230457. doi:10.1148/radiol.230457
  • Wei H, Fu F, Jiang H, et al. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study. Eur Radiol. 2023;33(11):7631–7645. doi:10.1007/s00330-023-09725-7
  • Wei Y, Pei W, Qin Y, Su D, Liao H. Preoperative MR imaging for predicting early recurrence of solitary hepatocellular carcinoma without microvascular invasion. Eur J Radiol. 2021;138:109663. doi:10.1016/j.ejrad.2021.109663
  • Liang X, Shi S, Gao T. Preoperative gadoxetic acid-enhanced MRI predicts aggressive pathological features in LI-RADS category 5 hepatocellular carcinoma. Clin Radiol. 2022;77(9):708–716. doi:10.1016/j.crad.2022.05.018